Humacyte publications and clinical trials.


2019: “Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis patients with Medicare Coverage 2012-2014”



2019: “Cost Attributable to Arteriovenous Fistulae and Arteriovenous Graft Placements in Hemodialysis patients with Medicare Coverage”



Science Translational Medicine​

Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.

March 27, 2019



2017: “Arteriovenous fistulae for Hemodialysis: A Systematic Review and Meta-Anaylsis of Efficacy and Safety Outcomes”


The Lancet

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials

May 14, 2016

Science Translational Medicine​

Readily Available Tissue-Engineered Vascular Grafts

February 2, 2011


Clinical Trial for AV Access


Human Acellular Vessel – A Controlled Comparison
of Efficacy and Safety Study

Human Acellular Vessel vs. Arteriovenous Fistula
for Hemodialysis Access

Phase II Clinical Trial for Peripheral Arterial Disease

Scroll to Top